Digestive & Intestinal Remedies (Pharmacies) - Myanmar

  • Myanmar
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$27.00m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.79%, resulting in a market volume of US$34.11m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.49 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Myanmar is witnessing significant growth and development.

Customer preferences:
Customers in Myanmar have shown a growing preference for digestive and intestinal remedies. This can be attributed to several factors, including an increased awareness about digestive health and the availability of a wide range of products in the market. Additionally, the changing dietary habits and lifestyles of the population have also contributed to the rising demand for these remedies.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies (Pharmacies) market in Myanmar is the increasing popularity of natural and herbal remedies. Customers are increasingly seeking products that are made from natural ingredients and are perceived to be safer and more effective. This trend is in line with the global shift towards natural and organic products in the healthcare industry. Another trend in the market is the growing preference for over-the-counter (OTC) remedies. Customers are increasingly opting for self-medication and are looking for easily accessible remedies that can be purchased without a prescription. This trend is driven by factors such as convenience, cost-effectiveness, and a desire for greater control over one's healthcare.

Local special circumstances:
Myanmar has a rich tradition of traditional medicine, which includes various remedies for digestive and intestinal ailments. This has influenced customer preferences and has contributed to the demand for herbal and natural remedies in the market. Additionally, the relatively low cost of healthcare in Myanmar compared to other countries in the region has also made these remedies more affordable and accessible to the population.

Underlying macroeconomic factors:
The growing Digestive & Intestinal Remedies (Pharmacies) market in Myanmar can be attributed to several macroeconomic factors. Firstly, the country has been experiencing rapid economic growth in recent years, which has led to an increase in disposable income and improved living standards. This has resulted in a higher demand for healthcare products and services, including digestive and intestinal remedies. Furthermore, the government of Myanmar has been actively promoting the development of the healthcare sector, including the pharmaceutical industry. This has led to an increase in investments and the establishment of more pharmacies and healthcare facilities across the country. The government's efforts to improve healthcare infrastructure and access to quality healthcare services have also contributed to the growth of the Digestive & Intestinal Remedies market. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Myanmar is experiencing significant growth and development. Customer preferences for natural and herbal remedies, as well as the increasing popularity of over-the-counter products, are driving the market. Local special circumstances, such as the traditional medicine practices and the affordability of healthcare, are also influencing the market. The underlying macroeconomic factors, including economic growth and government initiatives, are further contributing to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)